Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-06-07

FDA Approved: NAPROXEN — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approves Camber's naproxen generic original application for Naproxen. This generic NSAID is approved for relief of pain and inflammation in several indicati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naproxen (Naproxen)

Snippet

ORIG AP for NAPROXEN (NAPROXEN)